|
MRPL49 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.88178419700125E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-16 |
| Normal-vs-Stage2 |
3.99189999999994E-05 |
| Normal-vs-Stage3 |
9.58200000455989E-08 |
| Normal-vs-Stage4 |
7.63080043597597E-10 |
| Stage1-vs-Stage2 |
3.414000E-01 |
| Stage1-vs-Stage3 |
9.140000E-01 |
| Stage1-vs-Stage4 |
2.545800E-01 |
| Stage2-vs-Stage3 |
4.468400E-01 |
| Stage2-vs-Stage4 |
1.289000E-01 |
| Stage3-vs-Stage4 |
3.915800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.44089209850063E-16 |
| Normal-vs-AfricanAmerican |
1.12132525487141E-14 |
| Normal-vs-Asian |
1.142350E-02 |
| Caucasian-vs-AfricanAmerican |
9.501800E-01 |
| Caucasian-vs-Asian |
3.862000E-01 |
| AfricanAmerican-vs-Asian |
3.101600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.41442413337245E-13 |
| Male-vs-Female |
2.796600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.74145159298678E-14 |
| Normal-vs-Extreme_Weight |
1.11022302462516E-16 |
| Normal-vs-Obese |
4.96602758914833E-13 |
| Normal-vs-Extreme_Obese |
2.797300E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.634400E-01 |
| Normal_Weight-vs-Obese |
2.245200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.204000E-01 |
| Extreme_Weight-vs-Obese |
3.999600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.499800E-01 |
| Obese-vs-Extreme_Obese |
6.915200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.86040000000176E-05 |
| Normal-vs-Age(41-60Yrs) |
1.63402624764331E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.189170E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.363000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.679400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.567200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.232300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.574800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.070600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.22044604925031E-16 |
| Normal-VS-Type2 PRCC |
1.16351372980716E-13 |
| Normal-VS-KIRP CIMP |
4.24080000005489E-08 |
| Normal-VS-Unclassified PRCC |
6.80640000028099E-07 |
| Type1 PRCC-VS-Type2 PRCC |
9.843200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.804400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.398300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.248600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.586450E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.700800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.02158339752168E-12 |
| Normal-vs-N1 |
1.77169390269682E-12 |
| Normal-vs-N2 |
2.33239999536394E-08 |
| N0-vs-N1 |
3.014000E-01 |
| N0-vs-N2 |
1.723630E-01 |
| N1-vs-N2 |
2.696600E-01 |
|
|
